Int. J. Mol. Sci. 2013, 14(11), 23063-23085; doi:10.3390/ijms141123063
Review

Nutraceuticals: Potential for Chondroprotection and Molecular Targeting of Osteoarthritis

1,2email, 1,2email, 1email, 1email, 1email and 1,2,* email
Received: 16 August 2013; in revised form: 30 October 2013 / Accepted: 1 November 2013 / Published: 21 November 2013
(This article belongs to the Special Issue The Chondrocyte Phenotype in Cartilage Biology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Osteoarthritis (OA) is a degenerative joint disease and a leading cause of adult disability. There is no cure for OA, and no effective treatments which arrest or slow its progression. Current pharmacologic treatments such as analgesics may improve pain relief but do not alter OA disease progression. Prolonged consumption of these drugs can result in severe adverse effects. Given the nature of OA, life-long treatment will likely be required to arrest or slow its progression. Consequently, there is an urgent need for OA disease-modifying therapies which also improve symptoms and are safe for clinical use over long periods of time. Nutraceuticals—food or food products that provide medical or health benefits, including the prevention and/or treatment of a disease—offer not only favorable safety profiles, but may exert disease- and symptom-modification effects in OA. Forty-seven percent of OA patients use alternative medications, including nutraceuticals. This review will overview the efficacy and mechanism of action of commonly used nutraceuticals, discuss recent experimental and clinical data on the effects of select nutraceuticals, such as phytoflavonoids, polyphenols, and bioflavonoids on OA, and highlight their known molecular actions and limitations of their current use. We will conclude with a proposed novel nutraceutical-based molecular targeting strategy for chondroprotection and OA treatment.
Keywords: nutraceuticals; osteoarthritis; molecular targets
PDF Full-text Download PDF Full-Text [403 KB, uploaded 19 June 2014 05:17 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Leong, D.J.; Choudhury, M.; Hirsh, D.M.; Hardin, J.A.; Cobelli, N.J.; Sun, H.B. Nutraceuticals: Potential for Chondroprotection and Molecular Targeting of Osteoarthritis. Int. J. Mol. Sci. 2013, 14, 23063-23085.

AMA Style

Leong DJ, Choudhury M, Hirsh DM, Hardin JA, Cobelli NJ, Sun HB. Nutraceuticals: Potential for Chondroprotection and Molecular Targeting of Osteoarthritis. International Journal of Molecular Sciences. 2013; 14(11):23063-23085.

Chicago/Turabian Style

Leong, Daniel J.; Choudhury, Marwa; Hirsh, David M.; Hardin, John A.; Cobelli, Neil J.; Sun, Hui B. 2013. "Nutraceuticals: Potential for Chondroprotection and Molecular Targeting of Osteoarthritis." Int. J. Mol. Sci. 14, no. 11: 23063-23085.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert